triazoles has been researched along with Hyperlipemia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, TB; Liu, B; Liu, WQ; Luo, XJ; Ma, QL; Peng, J; Wu, Y; Xiong, XM; Zhang, JJ | 1 |
| Belal, TS; El-Yazbi, AF; Elnaggar, MM; Hamdy, DA; Khalil, HA | 1 |
| Belal, TS; El-Yazbi, AF; ElKhatib, MAW; Hamdy, DA; Khalil, HA | 1 |
| Arribas López, JR | 1 |
| Fontés, G; Hagman, DK; Latour, MG; Poitout, V; Semache, M | 1 |
| Brahmkshatriya, PS; Chhabria, MT; Raval, PM; Suhagia, BN | 1 |
| Cai, RG; Li, Q; Lu, HH; Wang, JY; Xu, BH; Yuan, P; Zhang, P | 1 |
| Samuels, S; Thompson, M | 1 |
| Monaghan, MS; Skrabal, MZ; Stading, JA | 1 |
| Bullock, WH; Burns, M; Chen, L; Claus, T; Daly, M; Dela Cruz, FE; Ehrgott, FJ; Johnson, JS; Livingston, JN; Ma, X; Majumdar, D; Rudolph, J; Schoenleber, RW; Shapiro, J; Tsutsumi, M; Yang, L | 1 |
| Day, P; ElSourady, H; Hall, IH; Izydore, RA; Simlot, R; Wong, OT | 1 |
1 review(s) available for triazoles and Hyperlipemia
| Article | Year |
|---|---|
[Secondary effects of treatment with maraviroc and other CCR5 antagonists. Potential impact of the CCR5 blocker].
Topics: Adult; Benzoates; CCR5 Receptor Antagonists; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Comorbidity; Cyclohexanes; Diketopiperazines; Disease Susceptibility; Drug Design; env Gene Products, Human Immunodeficiency Virus; HIV Fusion Inhibitors; HIV Infections; Homozygote; Humans; Hyperlipidemias; Incidence; Infections; Maraviroc; Membrane Fusion; Neoplasms; Piperazines; Receptors, CCR5; Sequence Deletion; Spiro Compounds; Triazoles; Virus Attachment; Virus Internalization | 2008 |
10 other study(ies) available for triazoles and Hyperlipemia
| Article | Year |
|---|---|
Involvement of NADPH oxidases and non-muscle myosin light chain in senescence of endothelial progenitor cells in hyperlipidemia.
Topics: Animals; Azepines; Benzoxazoles; Cellular Senescence; Endothelial Progenitor Cells; Hyperlipidemias; Lipids; Male; Myosin Light Chains; Myosin-Light-Chain Kinase; NADPH Oxidases; Naphthalenes; Phosphorylation; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Messenger; RNA, Small Interfering; Triazoles | 2016 |
The effect of hyperlipidemia on the pharmacokinetics, hepatic and pulmonary uptake of posaconazole in rat.
Topics: Animals; Antifungal Agents; Hyperlipidemias; Liver; Lung; Poloxamer; Protein Binding; Rats, Sprague-Dawley; Tissue Distribution; Triazoles | 2016 |
Hyperlipidemia Alters the Pharmacokinetics of Posaconazole and Vincristine Upon Co-Administration in Rats.
Topics: Animals; Drug Interactions; Drug Therapy, Combination; Hyperlipidemias; Rats; Rats, Sprague-Dawley; Tissue Distribution; Triazoles; Vincristine | 2017 |
Lack of preservation of insulin gene expression by a glucagon-like peptide 1 agonist or a dipeptidyl peptidase 4 inhibitor in an in vivo model of glucolipotoxicity.
Topics: Analysis of Variance; Animals; Blood Glucose; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Eating; Exenatide; Fat Emulsions, Intravenous; Gene Expression; Glucagon-Like Peptide 1; Glucose; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Lipids; Male; Peptides; Pyrazines; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sitagliptin Phosphate; Triazoles; Venoms | 2010 |
Synthesis and antihyperlipidemic activity of some novel 4-(substitutedamino)-5-substituted-3-mercapto- (4H)-1,2,4-triazoles.
Topics: Animals; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Chromatography, Thin Layer; Drug Design; Female; Hyperlipidemias; Hypolipidemic Agents; Indicators and Reagents; Lipids; Magnetic Resonance Spectroscopy; Male; Poloxamer; Quantitative Structure-Activity Relationship; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Spectrophotometry, Infrared; Sulfhydryl Compounds; Triazoles; Triglycerides | 2011 |
[Effects of anastrozole on lipid metabolism in Chinese postmenopausal women with breast cancer].
Topics: Age Factors; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Follow-Up Studies; Humans; Hyperlipidemias; Lipid Metabolism; Lipids; Middle Aged; Neoplasm Staging; Nitriles; Postmenopause; Triazoles; Triglycerides | 2011 |
Rhabdomyolysis with simvastatin and nefazodone.
Topics: Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Interactions; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Piperazines; Rhabdomyolysis; Simvastatin; Triazoles | 2002 |
Rhabdomyolysis associated with simvastatin-nefazodone therapy.
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Piperazines; Rhabdomyolysis; Simvastatin; Triazoles | 2003 |
Indanylacetic acid derivatives carrying 4-thiazolyl-phenoxy tail groups, a new class of potent PPAR alpha/gamma/delta pan agonists: synthesis, structure-activity relationship, and in vivo efficacy.
Topics: Acetates; Animals; Apolipoprotein A-I; Cell Line; Cricetinae; Female; Humans; Hyperlipidemias; Hypoglycemic Agents; In Vitro Techniques; Indans; Lipids; Male; Mice; Mice, Transgenic; PPAR alpha; PPAR delta; PPAR gamma; Radioligand Assay; Rats; Rats, Zucker; Solubility; Stereoisomerism; Structure-Activity Relationship; Transcriptional Activation; Triazoles | 2007 |
The hypolipidemic effects of 1-acetyl-4-phenyl-1,2,4-triazolidine-3,5-dione in rodents.
Topics: Animals; Body Weight; Cholesterol; Diet; Eating; Feces; Hyperlipidemias; Hypolipidemic Agents; Intestine, Small; Lipid Metabolism; Lipoproteins; Liver; Male; Organ Size; Rats; Rats, Sprague-Dawley; Triazoles; Triglycerides | 1993 |